结直肠癌肝转移射频治疗的现状与进展

Current status and updates of radiofrequency ablation for colorectal liver metastasis

结直肠癌是常见的恶性肿瘤.随着我国的社会经济发展和生活方式的变化,其发病率呈逐年上升趋势.约50％结直肠癌患者可在病程发展的不同阶段出现肝转移.结直肠癌肝转移是导致结直肠癌患者死亡的重要原因.RFA是近年来应用于临床能够毁损肝转移癌的重要方法,因其具备精确性、微创性、可重复性等特点,作为一种有效的局部治疗方法被越来越广泛地应用于临床.笔者将对RFA治疗结直肠癌肝转移的适应证、RFA应用于不可切除结直肠癌肝转移及可切除结直肠癌肝转移治疗现状、RFA应用于结直肠癌肝转移联合治疗进行探讨.

Colorectal cancer is a kind of common malignant tumor,the incidence of which appears to increase with the developments of social economy and change of life style.Liver metastasis occurred in about 50％ of patients with colorectal cancer,as an important cause of death.In recent years,radiofrequency ablation （RFA） has been used clinically to damage the hepatic metastatic carcinoma.With the characteristics of accuracy,micro-invasive trauma and repeatability,RFA has been extensively used as an effective local treatment.This paper discusses the indications of RFA for colorectal liver metastasis （CRLM）,current status of RFA in unresectable and resectable CRLM,application of RFA in combine therapy for CRLM.